Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional

Safety and Effectiveness of Adding Saquinavir (FORTOVASE) in Soft Gel Capsule Form to an Anti-HIV Drug Combination in HIV-Infected Patients

ClinicalTrials.gov ID: NCT00002229

Public ClinicalTrials.gov record NCT00002229. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 4:28 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase IV, Non-Comparative Study to Evaluate FORTOVASE (Saquinavir) Soft Gel Capsule (SGC) TID Regimen in Combination With Two NRTI's in HIV-1 Infected Women and Men

Study identification

NCT ID
NCT00002229
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
80 participants

Conditions and interventions

Conditions

Interventions

  • Saquinavir Drug

Drug

Eligibility (public fields only)

Age range
16 Years to 64 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Jun 23, 2005

United States locations

U.S. sites
20
U.S. states
14
U.S. cities
17
Facility City State ZIP Site status
ASC Inc Hobson City Alabama 36201
Dean Martin Phoenix Arizona 85006
Wilbert Jordan Paramount California 90723
Whitman Walker Clinic Washington D.C. District of Columbia 20009
Duval County Health Department Jacksonville Florida 32206
Ctr for Quality Care Tampa Florida 33609
NTouch Research Corp Decatur Georgia 30033
Univ of Illinois Hosp at Chicago Chicago Illinois 60612
Univ of Kentucky Lexington Kentucky 40536
C100 HIV Outpatient Program New Orleans Louisiana 70112
NJ CRI Newark New Jersey 07103
UMDNJ / Dept of Ob/Gyn Newark New Jersey 07103
SUNY Health Sciences Ctr Brooklyn New York 11203
Brookdale Univ Med Ctr Brooklyn New York 11212
Mt Vernon Hosp Mount Vernon New York 10550
Mount Sinai Med Ctr New York New York 100296574
Harlem Hosp Infectious Disease New York New York 10037
Mem Hosp of Rhode Island Pawtucket Rhode Island 02860
Diversified Med Practices, PA Houston Texas 77027
Univ of Virginia Health Sciences Ctr Charlottesville Virginia 22908

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00002229, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 23, 2005 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00002229 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →